438 related articles for article (PubMed ID: 18372392)
1. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling.
Qin B; Anderson RA; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1120-9. PubMed ID: 18372392
[TBL] [Abstract][Full Text] [Related]
2. Elevation of tumor necrosis factor-alpha induces the overproduction of postprandial intestinal apolipoprotein B48-containing very low-density lipoprotein particles: evidence for related gene expression of inflammatory, insulin and lipoprotein signaling in enterocytes.
Qin B; Dawson H; Anderson RA
Exp Biol Med (Maywood); 2010 Feb; 235(2):199-205. PubMed ID: 20404035
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
[TBL] [Abstract][Full Text] [Related]
4. Secretion of atherogenic risk factor apolipoprotein B-100 is increased by a potential mechanism of JNK/PKC-mediated insulin resistance in liver cells.
Jin UH; Kang YJ; Chang YC; Kim CH
J Cell Biochem; 2008 Feb; 103(3):908-19. PubMed ID: 17647275
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins.
Qin B; Qiu W; Avramoglu RK; Adeli K
Diabetes; 2007 Feb; 56(2):450-61. PubMed ID: 17259391
[TBL] [Abstract][Full Text] [Related]
6. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y
Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076
[TBL] [Abstract][Full Text] [Related]
7. LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.
Basciano H; Miller A; Baker C; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G323-32. PubMed ID: 19497957
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model.
Taghibiglou C; Carpentier A; Van Iderstine SC; Chen B; Rudy D; Aiton A; Lewis GF; Adeli K
J Biol Chem; 2000 Mar; 275(12):8416-25. PubMed ID: 10722675
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
Dekker MJ; Baker C; Naples M; Samsoondar J; Zhang R; Qiu W; Sacco J; Adeli K
Atherosclerosis; 2013 May; 228(1):98-109. PubMed ID: 23466071
[TBL] [Abstract][Full Text] [Related]
10. Cinnamon extract inhibits the postprandial overproduction of apolipoprotein B48-containing lipoproteins in fructose-fed animals.
Qin B; Polansky MM; Sato Y; Adeli K; Anderson RA
J Nutr Biochem; 2009 Nov; 20(11):901-8. PubMed ID: 18993048
[TBL] [Abstract][Full Text] [Related]
11. TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c).
Endo M; Masaki T; Seike M; Yoshimatsu H
Exp Biol Med (Maywood); 2007 May; 232(5):614-21. PubMed ID: 17463157
[TBL] [Abstract][Full Text] [Related]
12. Treatment with atorvastatin ameliorates hepatic very-low-density lipoprotein overproduction in an animal model of insulin resistance, the fructose-fed Syrian golden hamster: evidence that reduced hypertriglyceridemia is accompanied by improved hepatic insulin sensitivity.
Mangaloglu L; Cheung RC; Van Iderstine SC; Taghibiglou C; Pontrelli L; Adeli K
Metabolism; 2002 Apr; 51(4):409-18. PubMed ID: 11912545
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of apolipoprotein B secretion, but not lipid, by tumor necrosis factor-alpha in rat hepatocyte cultures in the absence of extracellular fatty acids.
Bartolomé N; Rodríguez L; Martínez MJ; Ochoa B; Chico Y
Ann N Y Acad Sci; 2007 Jan; 1096():55-69. PubMed ID: 17405916
[TBL] [Abstract][Full Text] [Related]
14. Effect of rosuvastatin on hepatic production of apolipoprotein B-containing lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia.
Chong T; Naples M; Federico L; Taylor D; Smith GJ; Cheung RC; Adeli K
Atherosclerosis; 2006 Mar; 185(1):21-31. PubMed ID: 16002078
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor (TNF) receptor-2-mediated DNA synthesis and proliferation in primary cultures of adult rat hepatocytes: The involvement of endogenous transforming growth factor-alpha.
Okamoto H; Kimura M; Watanabe N; Ogihara M
Eur J Pharmacol; 2009 Feb; 604(1-3):12-9. PubMed ID: 19100731
[TBL] [Abstract][Full Text] [Related]
16. Human resistin stimulates hepatic overproduction of atherogenic ApoB-containing lipoprotein particles by enhancing ApoB stability and impairing intracellular insulin signaling.
Costandi J; Melone M; Zhao A; Rashid S
Circ Res; 2011 Mar; 108(6):727-42. PubMed ID: 21293001
[TBL] [Abstract][Full Text] [Related]
17. Intestinal assembly and secretion of highly dense/lipid-poor apolipoprotein B48-containing lipoprotein particles in the fasting state: evidence for induction by insulin resistance and exogenous fatty acids.
Guo Q; Avramoglu RK; Adeli K
Metabolism; 2005 May; 54(5):689-97. PubMed ID: 15877301
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes.
Lorenzo M; Fernández-Veledo S; Vila-Bedmar R; Garcia-Guerra L; De Alvaro C; Nieto-Vazquez I
J Anim Sci; 2008 Apr; 86(14 Suppl):E94-104. PubMed ID: 17940160
[TBL] [Abstract][Full Text] [Related]
19. Both insulin resistance and diabetes in Psammomys obesus upregulate the hepatic machinery involved in intracellular VLDL assembly.
Zoltowska M; Ziv E; Delvin E; Lambert M; Seidman E; Levy E
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):118-23. PubMed ID: 14604833
[TBL] [Abstract][Full Text] [Related]
20. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]